{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:32:30Z","timestamp":1790314350314,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1038\/4031","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:43:54Z","timestamp":1027673034000},"page":"1438-1440","source":"Crossref","is-referenced-by-count":113,"title":["In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model"],"prefix":"10.1038","volume":"4","author":[{"given":"Christian W.","family":"Mandl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith H.","family":"Aberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan W.","family":"Aberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz X.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm1298_1438_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02752256","volume":"8","author":"G Ada","year":"1997","unstructured":"Ada, G. Overview of vaccines. Mol. Biotechnol. 8, 123\u2013 134 (1997).","journal-title":"Mol. Biotechnol."},{"key":"BFnm1298_1438_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nm0598supp-515","volume":"4","author":"MA Liu","year":"1998","unstructured":"Liu, M.A. Vaccine developments. Nature Med. 4, 515\u2013519 (1998).","journal-title":"Nature Med"},{"key":"BFnm1298_1438_CR3","first-page":"9","volume":"75","author":"JC Petricciani","year":"1991","unstructured":"Petricciani, J.C. Regulatory philosophy and acceptability of cells for the production of biologicals. Dev. Biol. Stand. 75, 9\u2013 15 (1991).","journal-title":"Dev. Biol. Stand"},{"key":"BFnm1298_1438_CR4","first-page":"889","volume-title":"Vaccines","author":"PD Parkman","year":"1994","unstructured":"Parkman, P.D. & Hardegree, M.C. in Vaccines 2nd edn. (eds. Plotkin, S.A. & Mortimer, E.A.) 889\u2013 901 (W.B. Saunders, Philadelphia, Pennsylvania, 1994)."},{"key":"BFnm1298_1438_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/biol.1997.0055","volume":"25","author":"DJ Wood","year":"1997","unstructured":"Wood, D.J. & Macadam, A.J. Laboratory tests for live attenuated poliovirus vaccines. Biologicals 25, 3\u2013 15 (1997).","journal-title":"Biologicals"},{"key":"BFnm1298_1438_CR6","first-page":"415","volume-title":"Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses","author":"G Wengler","year":"1995","unstructured":"Wengler, G. et al. in Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses (eds. Murphy, F.A. et al.) 415\u2013 427 (Springer-Verlag, Vienna, Austria,1995)."},{"key":"BFnm1298_1438_CR7","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/JVI.72.3.2132-2140.1998","volume":"72","author":"CW Mandl","year":"1998","unstructured":"Mandl, C.W. et al. Spontaneous and engineered deletion in the 3\u00b4 noncoding region of tick-borne encephalitis virus: Construction of highly attenuated mutants of a flavivirus. J. Virol. 72, 2132\u20132140 (1998).","journal-title":"J. Virol."},{"key":"BFnm1298_1438_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1128\/CMR.8.3.406","volume":"8","author":"FR Vogel","year":"1995","unstructured":"Vogel, F.R. & Sarver, N. Nucleic acid vaccines. Clin. Microbiol. Rev. 8, 406\u2013410 (1995).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnm1298_1438_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1615\/CritRevImmunol.v17.i2.20","volume":"17","author":"E Manickan","year":"1997","unstructured":"Manickan, E., Karem, K.L. & Rouse, B.T. DNA vaccines \u2013 a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17, 139\u2013154 (1997).","journal-title":"Crit. Rev. Immunol."},{"key":"BFnm1298_1438_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1023\/A:1011950415325","volume":"15","author":"G Gregoriadis","year":"1998","unstructured":"Gregoriadis, G. Genetic vaccines: strategies for optimization. Pharm. Res. 15, 661\u2013670 (1998).","journal-title":"Pharm. Res."},{"key":"BFnm1298_1438_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","volume":"15","author":"JJ Donnelly","year":"1997","unstructured":"Donnelly, J.J., Ulmer, J.B., Shiver, J.W. & Liu, M.A. DNA vaccines. Annu. Rev. Immunol. 15, 617\u2013648 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm1298_1438_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1096\/fasebj.11.10.9271360","volume":"11","author":"M Chattergoon","year":"1997","unstructured":"Chattergoon, M., Boyer, J. & Weiner, D.B. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J. 11, 753\u2013 763 (1997).","journal-title":"FASEB J."},{"key":"BFnm1298_1438_CR13","first-page":"931","volume-title":"Fields Virology","author":"CM Rice","year":"1996","unstructured":"Rice, C.M. in Fields Virology, 3rd edn. (eds. Fields, B.N. et al. ) 931\u2013960 (Lippincott-Raven, Philadelphia, Pennsylvania, 1996)."},{"key":"BFnm1298_1438_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1099\/0022-1317-78-5-1049","volume":"78","author":"CW Mandl","year":"1997","unstructured":"Mandl, C.W., Ecker, M., Holzmann, H., Kunz, C. & Heinz, F.X. Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J. Gen. Virol. 78, 1049\u2013 1057 (1997).","journal-title":"J. Gen. Virol."},{"key":"BFnm1298_1438_CR15","first-page":"135","volume":"23","author":"RM Conry","year":"1996","unstructured":"Conry, R.M., LoBuglio, A.F. & Curiel, D.T. Polynucleotide-mediated immunization therapy of cancer. Semin. Oncol. 23, 135\u2013 147 (1996).","journal-title":"Semin. Oncol."},{"key":"BFnm1298_1438_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nbt0498-364","volume":"16","author":"SK Nair","year":"1998","unstructured":"Nair, S.K. et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnol. 16, 364\u2013 369 (1998).","journal-title":"Nature Biotechnol"},{"key":"BFnm1298_1438_CR17","first-page":"262","volume":"3","author":"P Qiu","year":"1996","unstructured":"Qiu, P., Ziegelhoffer, P., Sun, J. & Yang, N.S. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther. 3, 262\u2013268 (1996).","journal-title":"Gene Ther."},{"key":"BFnm1298_1438_CR18","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/0264-410X(94)90074-4","volume":"12","author":"X Zhou","year":"1994","unstructured":"Zhou, X. et al. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12, 1510\u20131514 (1994).","journal-title":"Vaccine"},{"key":"BFnm1298_1438_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0092-1157(86)90032-6","volume":"14","author":"FX Heinz","year":"1986","unstructured":"Heinz,, F.X., Tuma, W., Guirakhoo, F. & Kunz, C. A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J. Biol. Standard. 14, 133\u2013 141 (1986).","journal-title":"J. Biol. Standard."},{"key":"BFnm1298_1438_CR20","first-page":"493","volume":"27","author":"JL Reed","year":"1938","unstructured":"Reed, J.L. & Muench, H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27, 493 (1938).","journal-title":"Am. J. Hyg."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1298_1438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1298_1438","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1298_1438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:24:49Z","timestamp":1684448689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1298_1438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["BFnm1298_1438"],"URL":"https:\/\/doi.org\/10.1038\/4031","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}